Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantin Dumann

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 20, 2020
[Cutaneous manifestations of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation]Mirjana Ziemer, Konstantin Dumann
Journal of Clinical Medicine|April 12, 2022
Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years)Robin Reschke, Konstantin Dumann, Mirjana Ziemer
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 9, 2019
[Pitfall cryothermic dermatitis artefacta]Mirjana Ziemer, Manfred Kunz, Monica Schüürmann, et al.
The British Journal of Dermatology|March 9, 2022
Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibodyBenjamin Klein, Regina Treudler, Konstantin Dumann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 11, 2021
Lupus erythematosus: correlation of clinical and histological findings and proposal for a modified disease classificationAnne Weldemann, Marita Ziepert, Markus Kreuz, et al.
Lasers in Surgery and Medicine|October 4, 2018
Full ablative versus fractional ablative laser therapy for Dowling-Degos diseaseAnna-Theresa Seitz, Helen Sterz, Vincent Strehlow, et al.
Biosensors & Bioelectronics|September 12, 2018
A multidimensional impedance platform for the real-time analysis of single and combination drug pharmacology in patient-derived viable melanoma modelsDiana Seidel, Rebecca Rothe, Mandy Kirsten, et al.
Frontiers in Oncology|December 27, 2021
Case Report: Graft <i>Versus</i> Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary SyndromeGeorg-Nikolaus Franke, Konstantin Dumann, Madlen Jentzsch, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 20, 2020
[Cutaneous manifestations of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation]Mirjana Ziemer, Konstantin Dumann
Journal of Clinical Medicine|April 12, 2022
Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years)Robin Reschke, Konstantin Dumann, Mirjana Ziemer
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 9, 2019
[Pitfall cryothermic dermatitis artefacta]Mirjana Ziemer, Manfred Kunz, Monica Schüürmann, et al.
The British Journal of Dermatology|March 9, 2022
Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibodyBenjamin Klein, Regina Treudler, Konstantin Dumann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 11, 2021
Lupus erythematosus: correlation of clinical and histological findings and proposal for a modified disease classificationAnne Weldemann, Marita Ziepert, Markus Kreuz, et al.
Lasers in Surgery and Medicine|October 4, 2018
Full ablative versus fractional ablative laser therapy for Dowling-Degos diseaseAnna-Theresa Seitz, Helen Sterz, Vincent Strehlow, et al.
Biosensors & Bioelectronics|September 12, 2018
A multidimensional impedance platform for the real-time analysis of single and combination drug pharmacology in patient-derived viable melanoma modelsDiana Seidel, Rebecca Rothe, Mandy Kirsten, et al.
Frontiers in Oncology|December 27, 2021
Case Report: Graft <i>Versus</i> Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary SyndromeGeorg-Nikolaus Franke, Konstantin Dumann, Madlen Jentzsch, et al.
Pageof 1